Filing Details
- Accession Number:
- 0000939767-16-000272
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-14 19:34:05
- Reporting Period:
- 2016-11-09
- Filing Date:
- 2016-11-14
- Accepted Time:
- 2016-11-14 19:34:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc. | EXEL | Services-Commercial Physical & Biological Research (8731) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1387306 | Peter Lamb | C/O Exelixis, Inc. 210 E. Grand Ave. South San Francisco CA 94080 | Evp, Scientific Strategy & Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-11-09 | 50,000 | $5.04 | 123,600 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-11-09 | 20,000 | $5.50 | 143,600 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-11-09 | 70,000 | $13.15 | 73,600 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2016-11-09 | 50,000 | $0.00 | 50,000 | $5.04 |
| Common Stock | Option (right to buy) | Disposition | 2016-11-09 | 20,000 | $0.00 | 20,000 | $5.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-12-16 | 2018-12-15 | No | 4 | M | Direct |
| 55,000 | 2012-09-28 | 2018-09-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 16,024 | Indirect | By 401(k) |
Footnotes
- Includes 16,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2016.
- Represents 16,024 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 9, 2016.
- The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 16, 2012.
- The option, representing the right to purchase a total of 75,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015.
Billionaire Hedge Funds
